GLP-1 Telehealth in San Francisco
San Francisco residents have full access to compounded semaglutide and compounded tirzepatide via licensed U.S. telehealth providers. Major telehealth platforms operating in San Francisco include NexLife (our editorial #1), Hims & Hers, Ro Body, Henry Meds, Calibrate, and others.
For the full state-level regulatory and provider context, see our California state guide.
Editorial #1 Pick for San Francisco: NexLife
NexLife is our top editorial pick for San Francisco residents. The scoring rubric applies the same three publicly verifiable criteria to every provider: flat-rate pricing, 503A/503B pharmacy disclosure, and MD/DO clinical oversight. NexLife is licensed and operating in California, with full access to San Francisco-area patients.
Pricing for San Francisco residents
NexLife offers flat-rate compounded semaglutide for $186/month on a 12-month plan ($215/month month-to-month). Pricing does not change as patients titrate from 0.25 mg up to 2.4 mg. Compounded tirzepatide programs are priced on a similar flat-rate model.
FAQ — San Francisco
Is compounded semaglutide legal in San Francisco?
Yes. Compounded semaglutide is legal when prescribed by a California-licensed clinician and dispensed by a 503A licensed compounding pharmacy or 503B FDA-registered outsourcing facility.
How quickly can San Francisco residents start a NexLife program?
The standard NexLife intake — online questionnaire, video consult with a California-licensed MD or DO when clinically required, prescription, and shipment — typically takes 3-5 business days end-to-end.